Comparing one vs two heat treatments for cervical precancer in Kenya
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, effective way to treat cervical precancer and prevent cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 49 years old.
- You are living with HIV.
- You have not had a hysterectomy (surgery to remove the womb).
- You are not pregnant and it has been at least 6 weeks since giving birth.
- You have never been treated for cervical precancer or had cervical cancer.
- You tested positive for high-risk HPV or had an abnormal vinegar test (VIA) within the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, more effective way to prevent cervical cancer.
This study compares using one versus two probes during a heat treatment (thermal ablation) for early cervical changes in women living with HIV. The goal is to see which approach is more feasible and effective, hopefully preventing cervical cancer.
This study tests whether using one or two heat probes works better to remove cervical precancer in women with HIV. Participants will get treatment at a clinic in Rwanda and be checked again after 6 months.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
This study looks at how to improve cervical cancer screening and treatment for women living with HIV in Kenya. It involves group discussions to gather your views and experiences, which will help shape better care.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.